Yunzhen Qian

发表

Absolute Counts of Peripheral Lymphocyte Subsets Correlate with the Progression-Free Survival and Metastatic Status of Pancreatic Neuroendocrine Tumour Patients

Xianjun Yu, Chen Liu, Q. Ni, 2020, Cancer management and research.

Clinical implication of serum CA125 for the prediction of malignancy in mucinous cystic neoplasms of the pancreas

Xianjun Yu, Chen Liu, Q. Ni, 2020, Experimental and therapeutic medicine.

Prior history of acute pancreatitis predicts poor survival in patients with resectable pancreatic ductal adenocarcinoma.

Xianjun Yu, Chen Liu, Q. Ni, 2020, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Aberrant APOBEC3C expression induces characteristic genomic instability in pancreatic ductal adenocarcinoma

Yusheng Chen, Xuan Lin, Chen Liu, 2022, Oncogenesis.

Abstract. Carbohydrate antigen 19-9 (CA19-9) is the most important biomarker for pancreatic cancer. Approximately 5-10% of individuals are Lewis antigen negative with scarce secretion of CA19‐9 and fucosylation deficiency. However, the characteristics of Lewis-negative pancreatic cancer are uniden-

Xianjun Yu, Chen Liu, Q. Ni, 2020 .

Fibrinogen/Albumin Ratio as a Promising Marker for Predicting Survival in Pancreatic Neuroendocrine Neoplasms

Xianjun Yu, Chen Liu, G. Luo, 2021, Cancer management and research.

CMAR_A_275173 107..115

Xianjun Yu, Chen Liu, G. Luo, 2021 .

Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma

Xianjun Yu, Chen Liu, Q. Ni, 2020, Journal of Hematology & Oncology.

Prognostic Value of the C-Reactive Protein/Lymphocyte Ratio in Pancreatic Cancer

Xianjun Yu, Chen Liu, Chao Yang, 2020, Annals of Surgical Oncology.

Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter.

Xianjun Yu, Chen Liu, Q. Ni, 2020, Biochimica et biophysica acta. Reviews on cancer.

High pre-operative fasting blood glucose levels predict a poor prognosis in patients with pancreatic neuroendocrine tumour

Xianjun Yu, Chen Liu, Q. Ni, 2020, Endocrine.

Lewis antigen-negative pancreatic cancer: An aggressive subgroup

Xianjun Yu, Chen Liu, Q. Ni, 2020, International journal of oncology.

Carbohydrate antigen 125 supplements carbohydrate antigen 19-9 for the prediction of invasive intraductal papillary mucinous neoplasms of the pancreas

Xianjun Yu, Chen Liu, G. Luo, 2021, World Journal of Surgical Oncology.

Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma

Yusheng Chen, Xianjun Yu, Chen Liu, 2022, Journal of immunology research.

Predictive Values of Preoperative Markers for Resectable Pancreatic Body and Tail Cancer Determined by MDCT to Detect Occult Metastases

Xianjun Yu, Chen Liu, G. Luo, 2021, World Journal of Surgery.

A novel immune checkpoint score system for prognostic evaluation in pancreatic adenocarcinoma

Yusheng Chen, Xuan Lin, Chen Liu, 2023, BMC Gastroenterology.

HNF-1a promotes pancreatic cancer growth and apoptosis resistance via its target gene PKLR.

Chao Yang, Xianjun Yu, Chen Liu, 2020, Acta biochimica et biophysica Sinica.

Resected Pancreatic Cancer With N2 Node Involvement Is Refractory to Gemcitabine-Based Adjuvant Chemotherapy

Xianjun Yu, Chen Liu, Q. Ni, 2020, Cancer control : journal of the Moffitt Cancer Center.

High GFPT1 expression predicts unfavorable outcomes in patients with resectable pancreatic ductal adenocarcinoma

Xianjun Yu, Chen Liu, Q. Ni, 2021, World Journal of Surgical Oncology.